Hypo magnesium 5 mark answer

Reading File

Finding Sources

Reading File

Loading Image

I now have comprehensive information from multiple authoritative sources. Here is the full 5-mark answer:

Hypomagnesemia

Definition

Hypomagnesemia is defined as a serum magnesium concentration below 1.7 mg/dL (0.7 mmol/L). It must be distinguished from magnesium deficiency, which refers to a deficit in total body magnesium stores; hypomagnesemia refers to low circulating magnesium concentrations. Since serum levels may not reflect total body stores, clinical diagnosis relies on both lab values and symptoms.

Causes

Causes are broadly classified into reduced GI absorption, increased renal losses, and miscellaneous categories. The fractional excretion of magnesium (FEMg) helps distinguish GI from renal causes.

Fig. 11.25 - Causes of hypomagnesemia (Comprehensive Clinical Nephrology, 7th ed.)

1. Gastrointestinal Causes

Reduced intake: Protein-calorie malnutrition, prolonged fasting, prolonged IV therapy without supplementation
Malabsorption: Nontropical sprue (celiac disease), steatorrhea, short bowel syndrome (massive small bowel resection)
GI losses: Severe diarrhea, intestinal and biliary fistulae, excessive purgative use
Chronic alcoholism: Most common cause in hospitalized patients - due to marked nutritional deficiency and some inappropriate renal wasting
Acute pancreatitis: Saponification of magnesium in necrotic fat
Proton pump inhibitors (PPIs): Inhibit intestinal magnesium absorption; chronic use is associated with hypomagnesemia

2. Renal (Urinary) Causes

Diuretics: Most common acquired cause
- Loop diuretics (furosemide): block NKCC2 cotransporter in the thick ascending limb (TAL), reducing the electrochemical driving force for paracellular Mg²⁺ reabsorption
- Thiazide diuretics: block NCC cotransporter in the distal convoluted tubule (DCT), which colocalizes with TRPM6 channel, reducing magnesium reabsorption
Nephrotoxic drugs: Aminoglycosides (gentamicin), cisplatin, amphotericin B, calcineurin inhibitors (cyclosporine, tacrolimus), anti-EGFR monoclonal antibodies (cetuximab, panitumumab)
Hypercalcemia: Activates CaSR in the TAL, inducing renal Mg²⁺ wasting
High urinary output states: Polyuric phase of AKI, post-obstructive polyuria, post-transplant polyuria, osmotic diuresis (diabetes with glycosuria/ketoacidosis)
Metabolic acidosis, hyperthyroidism, primary aldosteronism

3. Hereditary/Genetic Disorders

Bartter syndrome: Autosomal recessive; mutations in TAL transporters (NKCC2, ROMK, CLCNKB) - "loop diuretic-like effect"; presents with hypokalemia, hypomagnesemia, metabolic alkalosis, growth retardation
Gitelman syndrome: Autosomal recessive; NCC mutation - "thiazide-like effect"; presents with hypomagnesemia, hypokalemia, hypocalciuria, metabolic alkalosis

Clinical Features

Clinical manifestations depend on the severity and rate of depletion. Symptoms become more common when serum Mg falls below 1.2 mg/dL.

Neuromuscular

Generalized weakness
Neuromuscular hyperexcitability: hyperreflexia, tremors, carpopedal spasm, tetany
Seizures (severe deficiency)
Positive Chvostek's and Trousseau's signs (often due to accompanying hypocalcemia)

Cardiac

Prolonged QT interval
ST depression
Torsades de pointes (life-threatening; seen especially post-surgery)
Potentiation of digoxin toxicity

Metabolic Consequences (Co-electrolyte Disturbances)

Hypocalcemia: Hypomagnesemia blunts PTH secretion and action (relative hypoparathyroidism), causing hypocalcemia and reduced calcitriol synthesis. This is a classic cause of PTH-resistant hypocalcemia.
Hypokalemia: Occurs in ~40% of hypomagnesemia patients. Decreased intracellular Mg²⁺ impairs ATP production, reduces Na⁺/K⁺-ATPase activity, causing K⁺ to leak into the tubular lumen. This hypokalemia is refractory to potassium replacement until magnesium is repleted first.
Hypophosphatemia and hyponatremia may also occur.

Treatment

Severity	Route	Regimen
Mild / Asymptomatic	Oral	Magnesium oxide, hydroxide, chloride, lactate, or pidolate salts (limited by GI side effects - diarrhea)
Symptomatic / Moderate-Severe	IV	Magnesium sulfate (MgSO₄): 8-12 g over first 24 hours, then 4-6 g/day for 3-4 days
Torsades de pointes	IV bolus	MgSO₄ 1-2 g IV over 5 minutes (ACC/AHA recommendation)
Eclampsia	IV	MgSO₄ - more effective than phenytoin for seizure control

Important points:

1 g of MgSO₄ contains 0.1 g of elemental magnesium
In renal insufficiency: reduce dose by 50-75%; monitor deep tendon reflexes (loss signals toxicity)
Severe hypomagnesemia (<1.0 mEq/L) requires sustained therapy due to slow equilibration with intracellular stores
Potassium-sparing diuretics (amiloride, triamterene) help in chronic renal Mg wasting by blocking DCT sodium channels
Correct hypomagnesemia before correcting hypokalemia or it will remain refractory

Key Points Summary (Exam Mnemonics)

"ReGiMen" of causes: Renal losses, GI losses, Malnutrition/drugs
Always check Mg when K is low and resistant to replacement
Torsades = Think Mg (first-line treatment is IV MgSO₄)
Hypomagnesemia → Hypoparathyroidism → Hypocalcemia (PTH blunting pathway)
ICU prevalence: 11-65% (usually asymptomatic but associated with mortality)

Sources: Comprehensive Clinical Nephrology 7th Ed., Sabiston Textbook of Surgery, Tintinalli's Emergency Medicine

This is a shared conversation. Sign in to Orris to start your own chat.